Dermata Therapeutics Statistics

Total Valuation

DRMA has a market cap or net worth of $5.07 million. The enterprise value is -$2.53 million.

Market Cap	5.07M
Enterprise Value	-2.53M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

DRMA has 4.02 million shares outstanding. The number of shares has increased by 505.46% in one year.

Current Share Class	4.02M
Shares Outstanding	4.02M
Shares Change (YoY)	+505.46%
Shares Change (QoQ)	+10.16%
Owned by Insiders (%)	20.99%
Owned by Institutions (%)	8.09%
Float	3.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.52
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.79

Current Ratio	4.79
Quick Ratio	4.59
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -194.20% and return on invested capital (ROIC) is -124.83%.

Return on Equity (ROE)	-194.20%
Return on Assets (ROA)	-85.25%
Return on Invested Capital (ROIC)	-124.83%
Return on Capital Employed (ROCE)	-124.91%
Weighted Average Cost of Capital (WACC)	7.02%
Revenue Per Employee	n/a
Profits Per Employee	-$839,840
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.95% in the last 52 weeks. The beta is 0.50, so DRMA's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-82.95%
50-Day Moving Average	1.29
200-Day Moving Average	3.36
Relative Strength Index (RSI)	48.46
Average Volume (20 Days)	86,359

Short Selling Information

The latest short interest is 200,344, so 4.98% of the outstanding shares have been sold short.

Short Interest	200,344
Short Previous Month	264,037
Short % of Shares Out	4.98%
Short % of Float	6.32%
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.77M
Pretax Income	-7.56M
Net Income	-7.56M
EBITDA	n/a
EBIT	-7.77M
Earnings Per Share (EPS)	-$8.16

Full Income Statement

Balance Sheet

The company has $7.52 million in cash and n/a in debt, giving a net cash position of $7.52 million or $1.87 per share.

Cash & Cash Equivalents	7.52M
Total Debt	n/a
Net Cash	7.52M
Net Cash Per Share	$1.87
Equity (Book Value)	6.22M
Book Value Per Share	2.34
Working Capital	6.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.76M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DRMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-505.46%
Shareholder Yield	-505.46%
Earnings Yield	-151.55%
FCF Yield	n/a

Analyst Forecast

The average price target for DRMA is $10.00, which is 693.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	693.65%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 1, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Aug 1, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1